ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

21,007Medicare Part D Prescriptions Filled, Including Refills

Rank: 8 out of 198

$888K Total Retail Price of All Prescriptions

Rank: 13 out of 198

628 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
10% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Nebraska
Lower avg

Schedule Two
Controlled Substances

6% of this provider’s 628 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

9% of this provider’s 628 patients filled at least one prescription for a schedule three drug, compared to an average of 10%.

Risky Drugs to Seniors

2% of this provider’s 20,169 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

23% of this provider’s prescriptions were for brand-name drugs, compared to an average of 25%.

Prescription Price

$42 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

33 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Nebraska
LEVOTHYROXINE SODIUM 1,083 1,020 1 1
SIMVASTATIN 947 896 2 2
AMLODIPINE BESYLATE 758 727 3 4
OMEPRAZOLE 666 650 4 3
POTASSIUM CHLORIDE 595 574 5 9
FUROSEMIDE 571 569 6 5
WARFARIN SODIUM 567 567 7 7
LOSARTAN POTASSIUM 479 472 8 18
METOPROLOL SUCCINATE 469 456 9 11
ATORVASTATIN CALCIUM 430 415 10 12
LISINOPRIL 428 415 11 6
METFORMIN HCL 377 346 12 13
PRAVASTATIN SODIUM 364 354 13 19
CARVEDILOL 329 319 14 24
TORSEMIDE 306 303 15 75
ATENOLOL 302 276 16 17
CITALOPRAM HBR 269 266 17 20
GABAPENTIN 230 229 18 14
QUINAPRIL HCL 228 207 19 145
SERTRALINE HCL 219 219 20 25
GLIPIZIDE ER 211 194 21 83
PREDNISONE 193 187 22 29
METOPROLOL TARTRATE 193 180 22 10
HYDROCODONE-ACETAMINOPHEN 191 191 S3 24 8
ZOLPIDEM TARTRATE 190 190 25 22
ALLOPURINOL 185 185 26 23
CRESTOR 176 150 27 26
FELODIPINE ER 171 170 28 163
TAMSULOSIN HCL 160 158 29 27
ISOSORBIDE MONONITRATE ER 158 158 30 60
RAMIPRIL 152 128 31 72
ALENDRONATE SODIUM 144 132 32 21
RANITIDINE HCL 143 118 33 54
DONEPEZIL HCL 137 137 34 28
ZETIA 135 130 35 68
GLIPIZIDE XL 128 121 36 152
CARBIDOPA-LEVODOPA 122 122 37 71
CLONIDINE HCL 114 114 38 52
LOVASTATIN 112 106 39 70
GLIPIZIDE 112 112 39 62
PANTOPRAZOLE SODIUM 112 112 39 31
TRAMADOL HCL 110 109 42 15
DIGOXIN 106 106 43 43
NEXIUM 103 100 44 40
LEVOFLOXACIN 101 97 45 81
NADOLOL 100 97 46 206
ACEBUTOLOL HCL 98 98 47 238
SYNTHROID 98 93 47 36
RISPERIDONE 98 63 47 82
MELOXICAM 97 97 50 30
MIRTAZAPINE 96 96 51 44
GLIMEPIRIDE 92 92 52 35
CELEBREX 91 91 53 59
NAMENDA 86 86 54 33
TERAZOSIN HCL 84 84 55 102
DIOVAN 83 79 56 34
CLOPIDOGREL 82 82 57 42
POLYETHYLENE GLYCOL 3350 80 75 58 41
BYSTOLIC 80 80 58 58
PREMARIN 77 77 R 60 101
DILTIAZEM 24HR CD 77 77 60 126
KLOR-CON 10 74 70 62 131
FLURBIPROFEN 74 74 62 247
VERAPAMIL ER 74 61 62 117
PAROXETINE HCL 73 58 65 65
OXYBUTYNIN CHLORIDE 73 54 65 89
LEVEMIR FLEXPEN 71 71 67 149
ADVAIR DISKUS 71 71 67 47
DILTIAZEM ER 71 71 67 98
OXYCODONE-ACETAMINOPHEN 70 70 S2 70 79
KLOR-CON M10 68 68 71 125
FENTANYL 68 68 S2 71 73
FLUTICASONE PROPIONATE 66 62 73 39
HUMULIN 70-30 64 64 74 192
LABETALOL HCL 64 64 74 194
DIPHENOXYLATE-ATROPINE 64 52 74 191
TEKTURNA 63 58 77 224
AMLODIPINE BESYLATE-BENAZEPRIL 63 51 77 99
FENOFIBRATE 63 52 77 61
ESTRADIOL 63 60 R 77 172
NIASPAN 62 60 81 138
PENTOXIFYLLINE 61 61 82 264
BISOPROLOL-HYDROCHLOROTHIAZIDE 59 52 83 127
PRIMIDONE 58 58 84 200
NORTRIPTYLINE HCL 57 57 85 198
LANSOPRAZOLE 55 49 86 166
HYDROCHLOROTHIAZIDE 54 54 87 16
SULINDAC 53 53 88 281
TRIAMTERENE-HCTZ 53 49 88 32
CIPROFLOXACIN HCL 53 51 88 55
ESCITALOPRAM OXALATE 53 52 88 53
TRAZODONE HCL 52 48 92 50
VENLAFAXINE HCL ER 52 52 92 84
PROPRANOLOL HCL 52 52 92 92
FOSINOPRIL SODIUM 51 48 95 156
ACTOS 51 40 95 115
SPIRIVA 50 50 97 63
LOSARTAN-HYDROCHLOROTHIAZIDE 50 50 97 49
AMIODARONE HCL 50 50 97 119
GUANFACINE HCL 50 50 R 97 237
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 27, 2008.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.